Shares of Alembic Pharmaceuticals Ltd. rose 1.5% to Rs 773.5 apiece after the company received the U.S. FDA nod for its ANDA for Fesoterodine Fumarate Extended-Release tablets, 4 mg and 8 mg. It is indicated for treatment of overactive bladder in adults. The estimated market size of $225 million for twelve months ending September 2021, according to IQVIA.
Of the 18 analysts tracking the company, seven maintained ‘buy’, seven maintained ‘hold’ and four maintained ‘sell’ recommendations.The overall consensus price of analysts tracked by Bloomberg implied an upside of 11.1%.
Source: Exchange Filing, Bloomberg
Read More: Nifty Head towards 18,200 in Coming Months [02-02-2022]
Zydus Begins Supplying Covid-19 Vaccine ZyCoV-D To The Indian Government
- The government had placed an order of 1 crore doses with the company.
- The company is also planning to make the vaccine available in the private market.
- ZyCoV-D is a three dose vaccine administered intradermally over 56 days.
- The vaccine will be priced at Rs 265 per dose and its applicator will be offered at Rs 93 per dose excluding GST.
Source: Exchange filing
Read More: Sensex, Nifty Open Higher; Banking Stocks Lead Advance
सोशल मीडिया अपडेट्स के लिए हमें
Facebook ( https://www.facebook.com/goldsilverreports/ )
linkedin (https://www.linkedin.com/in/nealbhai/ )
और Twitter ( https://twitter.com/goldsilverrepor ) पर फॉलो करें।
हमारी फ्री सर्विस और लोगो की paid सर्विस से कई गुना अच्छी है।
आपको हर दिन दिए जाएंगे 3 से 5 कॉल बिलकुल फ्री
हर CALL में PROFIT दिये जायेंगे
तो जल्दी से MCX CHANNEL को JOIN कर लो (NEAL BHAI REPORTS)
JOIN US CLICK HERE
EQUITY CHANNEL को JOIN कर लो (EQUITY FREE TIPS)
JOIN US CLICK HERE
